AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023

Rhea-AI Summary

AbCellera (Nasdaq: ABCL) will present at the SVB Securities Global Biopharma Conference on February 15, 2023, at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time). A live audio webcast of the presentation will be available on AbCellera's Investor Relations website, along with a replay after the event.

AbCellera specializes in finding antibodies through the analysis of natural immune systems, partnering with various drug developers to accelerate drug development while minimizing costs. For further details, visit www.abcellera.com.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that it will present at the SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023, at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time).

A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.

Source: AbCellera Biologics Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230130005739/en/

Inquiries

Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774

Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005

Investor Relations: Josephine Hellschlienger, Ph.D.; ir@abcellera.com, +1(778)729-9116

Source: AbCellera Biologics Inc.

FAQ

When is AbCellera presenting at the SVB Securities Global Biopharma Conference?

AbCellera will present on February 15, 2023, at 10:00 a.m. Pacific Time.

Where can I watch AbCellera's presentation at the conference?

You can watch the live audio webcast on AbCellera's Investor Relations website.

What is the purpose of AbCellera's participation in the conference?

AbCellera aims to showcase its technology and partnerships in drug development.

What technology does AbCellera focus on?

AbCellera focuses on finding and analyzing antibodies to help develop drugs for disease prevention and treatment.

What is AbCellera's stock symbol?

AbCellera's stock symbol is ABCL.